EU-backed metabolic syndrome project has health claim wins in sight

This content item was originally published on www.nutraingredients.com, a William Reed online publication.

By Shane STARLING contact

- Last updated on GMT

Related tags: European food safety, European union

EU-backed metabolic syndrome project has health claim wins in sight
Nick Henson is the Reading-based associate director at the International Food Network (IFN), a key player in the EU’s new multi-million euro, multi-partner Metabolic Syndrome-battling project, PATHWAY-27, that has health claim victories trained in its sights.

He tells us of the project’s multiple aims that include bridging a perceived gap in data and guidelines to win health claims in the European Union for three selected ingredients: Omega-3 form docosahexaenoic acid (DHA), beta-glucan and anthocyanins.

“A key output is providing a set of guidelines that will potentially help food companies when they are wanting to prepare health claims…this is one of the difficulties that has cropped up in recent times – the difficulty of presenting data to the EFSA [European Food Safety Authority] committee that is effective in generating an approved claim,”​ Henson said.

Market-viable ‘Bioactive-enriched foods (BEF)’ in broad food categories like bakery and dairy are the goal for the 5-year project via a better understanding of the mechanisms of action of the nutrients in question.

IFN will be looking to extend their work at Vitafoods in Geneva, Switzerland, next week.

Partners include the University of Bologna, the French Institut National de la Recherche Agronomique (INRA), the Karolinska Institutet (Sweden), the Max Rubner-Institut (Germany), the VTT Technical Research Centre of Finland, the German Cancer Research Center (DKFZ), the University of Leeds, the University of Southern Denmark, Campden BRI Hungary, the International Life Sciences Institute (ILSI), Lebensmittelversuchsanstalt (Austria), the European Commission Joint Research Centre-Institute for Health and Consumer Protection (IHCP), Giotto Biotech (Italy), NGB Genetics (Italy), Applications Santé des Lipides (France), Abro Biotec (Spain), Swedish Oat Fiber and ADEXGO Ltd (Hungary).

Metabolic syndrome refers to a range of maladies including coronary artery disease, stroke and Type-2 diabetes.

Related topics: Health, R&D, Ingredients

Related news

Related products

show more

Redefining fresh with premium maltogenic amylases

Redefining fresh with premium maltogenic amylases

DSM Food Specialties | 23-May-2022 | Technical / White Paper

Developed to address freshness challenges faced by bakers worldwide, DSM’s maltogenic amylase solutions enable the production of high-quality baked goods,...

The Era of the Mindful Nutritionist

The Era of the Mindful Nutritionist

Univar Europe Ltd. | 12-May-2022 | Technical / White Paper

Discover Wellness: Bakery Trends by Univar Solutions

Today's health-conscious consumers are increasingly demanding that ingredients...

The Era of the Mindful Nutritionist

The Era of the Mindful Nutritionist

Univar Solutions | 10-May-2022 | Technical / White Paper

Today's health-conscious consumers are increasingly demanding that ingredients are Better for Me and Better for the Planet.

Related suppliers

Follow us

Products

View more

Webinars